Third Update on Hepatology

EPGS events in 2001

Endosonography Live in Amsterdam
.
Preventie en Behandeling van Per- en Postoperatieve complicaties

Date

December 14 and 15, 2000
 

Organizing committee

E.A. Jones
R.A.F.M. Chamuleau
M.P.R. Cooreman
H.W. Reesink
 

International faculty

F.B. Bianchi                              Bologna, IT
M. Blomley                                London, UK
A.K. Burroughs                          London, UK
E.Elias                                      Birmingham, UK
P. Ferenci                                 Vienna, AU
S.G. Hubscher                           Birmingham, UK
R. Jalan                                     Edinburgh, UK
M.J. Müller                                 Kiel, GE
J. Neuberger                               Birmingham, UK
G. Paumgartner                          Munchen, GE
S.D. Taylor-Robinson                  London, UK
 

Sponsors

Dr. Falk Pharma GmbH
Tramedico International BV
Schering-Plough BV
GlaxoWellcome

       13.00  Introduction
       13.05  Diagnostic and genetic basis of benign recurrent
                 cholestasis and progressive familial intrahepatic
                 cholestasis
       13.30  Resolution of problems in diagnosing and treating
                 copper overload
       13.55  Prognostic and therapeutic implications of liver
                 disease-related autoantibodies
       14.20  Gene-directed approach to therapy of
                 cholangiocarcinoma
       14.45  Isolated liver perfusion for chemotherapy of hepatic
                 malignancy

       15.40  Recent advances in hepatic surgical techniques
       16.05  Cytokines and the liver
.
       17.20  Current status of treatment for chronic hepatitis C
       17.45  Clinical implications of hepatitis B mutants
.
       18.05  Buffet Dinner
.
    Friday December 15, 2000

        9.00  Live demonstrations
.
       10.35  Live demonstrations
       11.45  Hepatotoxic and therapeutic implications of bile
                 acids
.
       12.30  Lunch
.
       13.15  PET of the brain in liver disease 
       13.40  MRS of the brain in liver disease 
       14.05  Ultrasound contrast media and space-occupying
                 lesions the liver 

       14.50  Do we need to measure portal pressure for
                 primary prophylaxis of portal hypertension bleeding
       15.15  Current status of TIPS for variceal bleeding and
                 ascites 
       15.40  Assessment and treatment of malnutrition in 
                 cirrhosis
       16.05  Are there efficacious new treatments for pruritis
                 and fatigue
       16.30  Will chronic 'liver dialysis' become feasible

       17.15  Prevention and treatment of  post-transplantation
                 hepatitis B virus infection
       17.40  When to transplant? the role of  prognostic
                 modeling
       18.05  Surgical aspects of complications after liver
                 transplantation
       18.30  Pathological aspects of hepatobiliary complications
       18.55  Auxiliary liver transplantation
       19.20  Long-term outcome of liver transplantation
       19.45  Discussion

.
R.H. Houwen
.
P. Ferenci
.
F.B. Bianchi
.
A.K. Groen.
.
C.H. vd Velde
..
T.M. v Gulik
S. v Deventer
.
H.W. Reesink
M. Cooreman.
.
.
.
.
..
.
.
.
.
G.Paumgartner

.
.
R. Jalan
S.D. Taylor
.
M. Blomley
.
.
A. Burroughs 

J.S. Lameris
.
M.J. Müller
.
E.A. Jones
R. Chamuleau
.
.
R.A. de Man
.
J. Neuberger
.
M.J.H. Slooff 
S.G Hubscher
J. Ringers 
E. Elias 

Registration:

Participants can register by completing the registration form and payment of the fee. Registration fee covers course participation, coffee/tea, lunch and dinner.

The Fee: NLG 600,- (EURO 270,-)
.
.
Information:
.
Further information, mailings and a registration form can be obtained through:

Mrs. Helma Stockmann
European Postgraduate Gastro-Surgical School 
Meibergdreef 9, G4 zuid
NL-1105 AZ Amsterdam
The Netherlands

Phone: +31 (20) 566 39 26 
Fax:     +31 (20) 566 65 69 
E-mail: